Schizophrenia is a complex mental disorder with multiple genetic and environmental factors contributing to its pathogenesis. Viral infections have been suggested to be one of the environmental factors associated with the development of this disorder. We comprehensively review all relevant published literature focusing on the relationship between schizophrenia and various viral infections, such as influenza virus, herpes virus 1 and 2 (HSV-1 and HSV-2), cytomegalovirus (CMV), Epstein-Barr virus (EBV), retrovirus, coronavirus, and Borna virus. These viruses may interfere with the normal maturation of the brain directly or through immune-induced mediators, such as cytokines, leading to the onset of schizophrenia. Changes in the expression of critical genes and elevated levels of inflammatory cytokines have been linked to virally-induced infections and relevant immune activities in schizophrenia. Future research is necessary to understand this relationship better and provide insight into the molecular mechanisms underlying the pathophysiology of schizophrenia.
Myocardial infarction is an emergency situation, and its early diagnosis is vital for patients and for the treatment which will be followed. Till now the diagnosis of myocardial infarction is based on the increased cardiac troponins I and T in the patient's serum, these biomarkers are the gold standard for the diagnosis of myocardial infarction but there are some limitations due to their slow release from the damaged myocytes. For this reason, new biomarkers are needed to be used for a faster diagnosis. New biomarkers should increase rapidly after acute myocardial infarction and should have cardiac selectivity. Myosin-binding protein C is a newly described candidate biomarker of cardiac injury and in small studies, it appears that its serum concentration decreases and increases faster than that of the troponin T and I. Cardiac troponins are released and cleared slowly after myocardial injury, complicating the diagnosis of an early and recurrent, acute myocardial infarction. Cardiac myosin-binding protein C is a similar cardiac protein that may have different release/clearance kinetics.
Schizophrenia is a severe mental disorder that affects approximately 1% of the population worldwide. Genetics and environmental factors appear to contribute to the pathogenesis of schizophrenia. Epidemiological studies have focused on the relationship between viral infection during pregnancy and an increased risk of developing schizophrenia in offspring. The aim of our review is to summarize whether viral infections during pregnancy can lead to psychiatric disorders and especially to schizophrenia in adulthood. For that purpose we undertaken a thorough search in Pubmed using as keywords viral infections, schizophrenia, perinatal infections and virus. Epidemiological studies have focused on the relationship between perinatal viral infections and an increased risk of developing schizophrenia in offspring. Influenza virus, various members of the Herpesviridae family, retroviruses, borna virus are discussed as examples of viral infections associated with schizophrenia. These viral infections appear to interfere with the normal maturation of the brain and may lead to the subsequent onset of schizophrenia. Another epidemiological aspect of schizophrenia is the fact that it presents a seasonal prevalence with peaks in offsprings which wer born during winter and spring. It is also possible for an infection occurring in infancy to reactivate later, as is known to happen with herpes viruses. Overall,various studies showed that prenatal maternal infections appear to increase the risk of developing schizophrenia in the offspring, and this is due to the body's immune response to the infection, and not in exposure to specific viral or bacterial pathogens.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.